Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combivir pilot study in primary biliary cirrhosis
ISRCTN22065123Phase 2Completed
- Sponsor
- United States Department of Health and Human Services
- Start
- Oct 2001
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of lamivudine + zidovudine in primary biliary cholangitis (PBC) (2 arms), sponsored by United States Department of Health and Human Services. Primary endpoint: Clinical endpoint. Started Oct 2001; status: completed.
02
Drugs
lamivudine + zidovudine
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on ISRCTN22065123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN22065123.